Paula Savage

676 total citations
40 papers, 528 citations indexed

About

Paula Savage is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Paula Savage has authored 40 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 22 papers in Cardiology and Cardiovascular Medicine and 14 papers in Molecular Biology. Recurrent topics in Paula Savage's work include Nitric Oxide and Endothelin Effects (31 papers), Renin-Angiotensin System Studies (14 papers) and Receptor Mechanisms and Signaling (5 papers). Paula Savage is often cited by papers focused on Nitric Oxide and Endothelin Effects (31 papers), Renin-Angiotensin System Studies (14 papers) and Receptor Mechanisms and Signaling (5 papers). Paula Savage collaborates with scholars based in United States, Switzerland and Australia. Paula Savage's co-authors include Arco Y. Jeng, Angelo J. Trapani, Paivi J. Kukkola, Stéphane De Lombaert, Charles W. Bruseo, A. Y. Jeng, Mary Chou, Dominick DelGrande, Eli M. Wallace and Daniël Hoyer and has published in prestigious journals such as Blood, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Paula Savage

39 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paula Savage United States 12 228 187 170 168 55 40 528
Russell D. Cousins United States 7 203 0.9× 173 0.9× 57 0.3× 82 0.5× 42 0.8× 7 500
Ross Bentley United States 19 212 0.9× 375 2.0× 143 0.8× 369 2.2× 48 0.9× 33 951
Alain Le Bec France 10 175 0.8× 482 2.6× 102 0.6× 210 1.3× 55 1.0× 11 643
Jonathan A. Winger United States 9 291 1.3× 332 1.8× 45 0.3× 91 0.5× 51 0.9× 14 611
Stephen J. Haleen United States 18 377 1.7× 371 2.0× 121 0.7× 294 1.8× 88 1.6× 31 822
Marie‐Claude Carrière Canada 13 210 0.9× 275 1.5× 215 1.3× 58 0.3× 82 1.5× 14 927
Eric Blasko United States 9 219 1.0× 212 1.1× 41 0.2× 103 0.6× 32 0.6× 12 741
F. S. TJOENG United States 9 179 0.8× 157 0.8× 86 0.5× 54 0.3× 32 0.6× 15 468
Yumi Sakane Switzerland 12 52 0.2× 222 1.2× 129 0.8× 199 1.2× 109 2.0× 22 572
Anthony H. Ingall United Kingdom 12 85 0.4× 240 1.3× 170 1.0× 173 1.0× 74 1.3× 14 789

Countries citing papers authored by Paula Savage

Since Specialization
Citations

This map shows the geographic impact of Paula Savage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Savage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Savage more than expected).

Fields of papers citing papers by Paula Savage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Savage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Savage. The network helps show where Paula Savage may publish in the future.

Co-authorship network of co-authors of Paula Savage

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Savage. A scholar is included among the top collaborators of Paula Savage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Savage. Paula Savage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Savage, Paula, et al.. (2009). Conversion of proendothelin-1 into endothelin-1 by aspartylproteases. International journal of peptide & protein research. 42(3). 227–232.
3.
Trapani, Angelo J., et al.. (2004). CGS 35601 and its Orally Active Prodrug CGS 37808 as Triple Inhibitors of Endothelin-converting Enzyme-1, Neutral Endopeptidase 24.11, and Angiotensin-converting Enzyme. Journal of Cardiovascular Pharmacology. 44(Supplement 1). S211–S215. 10 indexed citations
4.
Ksander, Gary M., Dominick DelGrande, Joseph L. Balwierczak, et al.. (2002). Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists. Canadian Journal of Physiology and Pharmacology. 80(5). 464–469. 1 indexed citations
5.
Gude, Candido, Kenneth Chan, Jenny Tan, et al.. (2002). Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1. Bioorganic & Medicinal Chemistry Letters. 12(21). 3059–3062. 9 indexed citations
6.
Gude, Candido, Kenneth Chan, Cynthia A. Fink, et al.. (2001). Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(3). 375–378. 9 indexed citations
7.
Trapani, Angelo J., Stéphane De Lombaert, Michael E. Beil, et al.. (2000). Cgs 34043. Life Sciences. 67(9). 1025–1033. 10 indexed citations
8.
Jeng, Arco Y., Stéphane De Lombaert, Michael E. Beil, et al.. (2000). Design and Synthesis of a Potent and Selective Endothelin-Converting Enzyme Inhibitor, CGS 35066. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S36–S39. 19 indexed citations
9.
Fink, Cynthia A., Daniël Hoyer, Ying Qiao, et al.. (2000). Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1. Bioorganic & Medicinal Chemistry Letters. 10(17). 2037–2039. 11 indexed citations
10.
Savage, Paula, Stéphane De Lombaert, Kohei Shimada, Kazuhiko Tanzawa, & Arco Y. Jeng. (1998). Differential Inhibition of Wild-Type Endothelin-Converting Enzyme-1 and Its Mutants. Journal of Cardiovascular Pharmacology. 31. S16–S18. 2 indexed citations
11.
Lombaert, Stéphane De, Louis Blanchard, Jenny Tan, et al.. (1997). Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11. Bioorganic & Medicinal Chemistry Letters. 7(8). 1059–1064. 26 indexed citations
12.
Jeng, Arco Y., et al.. (1996). Rat striatum contains pure population of ETB receptors. European Journal of Pharmacology. 300(3). 261–265. 8 indexed citations
13.
Kukkola, Paivi J., et al.. (1996). Optimization of retro-thiorphan for inhibition of endothelin converting enzyme. Bioorganic & Medicinal Chemistry Letters. 6(6). 619–624. 6 indexed citations
14.
Balwierczak, Joseph L., et al.. (1995). Characterization of a Potent and Selective Endothelin-B Receptor Antagonist, IRL 2500. Journal of Cardiovascular Pharmacology. 26. S393–396. 17 indexed citations
15.
Balwierczak, Joseph L., Paivi J. Kukkola, Paula Savage, & Arco Y. Jeng. (1995). Effects of metalloprotease inhibitors on smooth muscle endothelindashconverting enzyme activity. Biochemical Pharmacology. 49(3). 291–296. 5 indexed citations
16.
Savage, Paula & A. Y. Jeng. (1993). Quantitation of Plasma Endothelins. Analytical Biochemistry. 213(2). 434–436. 6 indexed citations
17.
Hsu, Linda, Paula Savage, & Arco Y. Jeng. (1992). Dual effects of endothelin-1 on neurite outgrowth induced by 12-O-tetradecanoylphorbol-13-acetate. Neuroscience Letters. 136(2). 219–222. 3 indexed citations
18.
Deng, Yilun, et al.. (1992). Identification and Partial Purification of a Thiol Endothelin- Converting Enzyme from Porcine Aortic Endothelial Cells. The Journal of Biochemistry. 111(3). 346–351. 10 indexed citations
19.
Savage, Paula, et al.. (1990). Affinity gel interactions of alcohol and polyol dehydrogenases: anomalous behaviour and structural correlations. Journal of Chromatography A. 502. 69–78. 3 indexed citations
20.
Jeng, A. Y., Paula Savage, Àlex Soriano, & Joseph L. Balwierczak. (1990). Different affinities and selectivities of endothelin-1 and endothelin-3 binding to various rat tissues.. PubMed. 22(4). 669–76. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026